Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis Joel Adu-Brimpong 1 , Jennifer Pugh 2 , David ... Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis Joel Adu-Brimpong et al. J Med Internet Res. ... Background: Digital therapeutics (DTx) are an emerging class of software-based medical therapies helping to improve care access ... Objective: We review current sociodemographic representation in DTx clinical trials using data from the Digital Therapeutics ...

Were sorry but RePORTER doesnt work properly without JavaScript enabled. Please enable it to continue. ...

NeuroHIV Therapeutics Program. Overview. This program supports the development of preventive and targeted adjunctive therapies ... Home , About NIMH , Offices and Divisions , Division of AIDS Research (DAR) , HIV Neuropathogenesis, Genetics, and Therapeutics ...

Catalogue: Medical Therapeutics. NLM has three items in manuscripts that are concerned with remedies and medical experiences ...

... * Occupational and Inhalation Exposures ... For therapeutics, the CPT program has engaged key partners for discussions regarding compound evaluations or questions of ... HIV Therapeutics: Evaluations of Combined Antiretroviral Combination Therapies. Subchronic study of Emtricitabine (FTC), ... The Consumer Products and Therapeutics (CPT) program in the NIEHS Division of Translational Toxicology (DTT) is structured ...

... : Read clinically focused news coverage of key developments from TCT 2017 ... Transcatheter Cardiovascular Therapeutics (TCT) 2017. October 29 - November 02, 2017; Denver, Colorado ...

The Cellular and Molecular Therapeutics Laboratory, led by Dr. John F. Tisdale, is working on multiple strategies both in the ... Cellular and Molecular Therapeutics. The Cellular and Molecular Therapeutics Laboratory, led by Dr. John F. Tisdale, is working ...

Conducts clinical and laboratory studies on the pathogenesis, diagnosis, treatment, and prevention of acute kidney injury in man and in animal models.

"License agreements for COVID-19 therapeutics" is developed to give information on licensesconcluded for therapeutics in the ... 2022)‎. License agreements for COVID-19 therapeutics, 2022. World Health Organization. Regional Office for South-East Asia. ... information in the brochure will serve as a quick guide for policy decision-making forintroduction of therapeutics in the ...

... Research Overview. Status: Ongoing. Substances: Codeine Phenolphthalein Emodin Emtricitabine (FTC) ... Medicines and therapeutics may be found in many forms, such as tablets, capsules, softgels, gelcaps, liquids, or powders. ... Medicines and therapeutics are substances used in the treatment of illnesses or symptoms. They are available to individuals ... Human Immunodeficiency Virus (HIV) Therapeutics. An estimated 35 million people worldwide are living with HIV. That number ...

Master Protocols for Therapeutics. The working group has assessed and designed multiple master protocols for ACTIV clinical ... An overview of the actual steps in the evaluation process that generates the final list of highly promising therapeutics for ... The clinical therapeutics fall into four categories (antivirals, immunomodulators, supportive therapies, and neutralizing ... these are described further on the ACTIV Therapeutics Page. View the clinical trial sites participating in the ACTIV master ...

... program seeks to identify novel ocular therapeutics that may be administered in a civilian first-responder or emergency care ... The CounterACT Ocular Therapeutics Screening (COTS) program seeks to identify novel ocular therapeutics that may be ...

Cognition Therapeutics, Inc.. Read about Cognition Therapeutics, a small business using NIA funding to develop therapeutics for ... Juvena Therapeutics, Inc.. Juvena Therapeutics, Inc., is a small business using NIA funding to advance a protein therapy for a ... Allyx Therapeutics, Inc.. Read about Allyx Therapeutics, Inc., a small business using NIA funding to develop an orally ... Ridgeline Therapeutics, LLC. Read about Ridgeline Therapeutics, a small business using NIA funding to further the development ...

HIV THERAPEUTICS: TARGETING RESEARCH GAPS Release Date: March 4, 1999 PA NUMBER: PA-99-067 P.T. National Institute of Allergy ... This PA, HIV Therapeutics: Targeting Research Gaps, is related to the priority area of HIV Infection. Potential applicants may ... Thus, therapeutics discovery and development remains a critical activity. To address these problems and to expand the ... RESEARCH OBJECTIVES Background The intense effort over the years in HIV therapeutics has paid off: critical viral enzymes (RT, ...

Assays for Influenza Therapeutics: Project BioShield NOT-AI-05-045. NIAID ... Assays for Influenza Therapeutics: Project BioShield Notice Number: NOT-AI-05-045 ... the NIAID is announcing a new grant initiative focused on assay development for influenza therapeutics. ... projects focused on the development of assays that are suitable for screening and development of influenza therapeutics. Actual ...

Developmental Therapeutics Program. The NCI Development Therapeutics Program (DTP) provides services and resources to the ... She served as Acting Associate Director of the DCTD Developmental Therapeutics Program beginning in January 2021 until her ...

Distributed by: Waylis Therapeutics LLC., Wixom, MI 48393 For more information, call . 1-303-557-7642. ...

Led by Dr. Hanna Kim, this unit studies juvenile myositis, including juvenile dermatomyositis, by comprehensively evaluating patients to better understand disease pathogenesis and conducting early phase clinical trials to evaluate new treatments.

PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Summit Therapeutics plc (NASDAQ: SMMT; ... Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics Inc., Motif Bio PLC, Nabriva Therapeutics US Inc., ... About Summit Therapeutics plc. Summit Therapeutics is a leader in antibiotic innovation. Summits new mechanism antibiotics are ... Paratek Pharmaceuticals Inc., SCYNEXIS Inc., Spero Therapeutics, Inc., Summit Therapeutics plc, T2 Biosystems Inc., Theravance ...

Biomolecules & Therapeutics. Vols. 20 to 31; 2012 to 2023. Vol. 31. 2023. v.31(1): 1-139. 2023 Jan 1. v.31(2): 141-239. 2023 ... Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology ...

RNA Therapeutics Institute (RTI) • 368 Plantation St Worcester, Massachusetts 01605 ¿Preguntas o comentarios? Correo ...

Novel therapeutics in hypertriglyceridemia Steven E Gryn et al. Curr Opin Lipidol. 2015 Dec. ...

ONK Therapeutics, has raised $21.5m in funding. ... Galway based ONK Therapeutics raises $21.5m Updated / Thursday ... Galway based cancer cell therapy start-up, ONK Therapeutics, has raised $21.5m in funding. ...

Voyager Therapeutics Inc. SEC filings breakout by MarketWatch. View the VYGR U.S. Securities and Exchange Commission reporting ...

ARMISTICE CAPITAL LLC Bought 736.0 Thousand shares of Bicycle Therapeutics PLC. Top 10 Owners of Bicycle Therapeutics PLC. ... JEFFERIES LLC Bought 1.9 Million shares of Bicycle Therapeutics PLC. 3/31/2023. MORGAN STANLEY & CO. LLC Bought 786.9 Thousand ... Top 10 Mutual Funds Holding Bicycle Therapeutics PLC. Mutual fund. Stake. Shares. owned. Total value ($). Shares. bought / sold ...